Fox Run Management, L.L.C. Monte Rosa Therapeutics, Inc. Transaction History
Fox Run Management, L.L.C.
- $608 Million
- Q1 2025
A detailed history of Fox Run Management, L.L.C. transactions in Monte Rosa Therapeutics, Inc. stock. As of the latest transaction made, Fox Run Management, L.L.C. holds 27,394 shares of GLUE stock, worth $106,014. This represents 0.02% of its overall portfolio holdings.
Number of Shares
27,394Holding current value
$106,014% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding GLUE
# of Institutions
106Shares Held
53.3MCall Options Held
69.1KPut Options Held
22.4K-
Nea Management Company, LLC Timonium, MD7.69MShares$29.8 Million3.39% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.64MShares$25.7 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA5.66MShares$21.9 Million1.15% of portfolio
-
Versant Venture Management, LLC San Francisco, CA5.65MShares$21.9 Million54.61% of portfolio
-
Baker Bros. Advisors LP New York, NY4.92MShares$19 Million0.27% of portfolio
About Monte Rosa Therapeutics, Inc.
- Ticker GLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,713,900
- Market Cap $181M
- Description
- Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...